ZEISS Cataract Suite markerless


Align toric IOLs and skip the manual marking and data transfer steps with products designed to work together for markerless toric IOL alignment.

Fast. Precise.1 Markerless. This is ZEISS Cataract Suite markerless. Gold standard products designed to work together; for a high level of precision1 and efficiency by skipping manual steps for toric IOL alignment. No manual marking means comfort for your patients and peace of mind for you.

ZEISS IOLMaster 500Precise1 alignment starts with excellent biometry from the IOLMaster® 500 from ZEISS. The new Option Reference Image is the starting point of a markerless toric IOL workflow.Building on gold standard biometry.

ZEISS CALLISTO eyeConnecting you and your devices, the computer assisted cataract surgery system CALLISTO eye® from ZEISS creates the overlays for the surgical microscope using data retrieved from the data management system FORUM® from ZEISS.Designed to work together.

ZEISS OPMI LUMERA family2All the information you need is injected into the eyepiece of the surgical microscopes of the OPMI LUMERA® family2 from ZEISS to assist in precise1 toric IOL alignment.Building on gold standard visualization.

ZEISS Cataract Suite markerless

  • Computer assisted surgery for precise1 toric IOL alignment.
  • Efficient and reliable data transfer from biometry to surgery.
  • No manual eye marking.

1Clinical data of Prof. Findl/Dr Hirnschall presented at ESCRS 2013 - technically verified pre-/intraoperative matching precision ± 1.0° in mean.2ZEISS Cataract Suite markerless is available with: S7 / OPMI Lumera, S88 / OPMI Lumera T, OPMI Lumera i and OPMI Lumera 700.

Contact us:www.meditec.zeiss.com/contactsWebsite:www.meditec.zeiss.com/iol

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.